Tangye Stuart G, Nichols Kim E, Hare Nathan J, van de Weerdt Barbara C M
Centenary Institute for Cancer Medicine and Cell Biology, Newtown 2042, Sydney, New South Wales, Australia.
J Immunol. 2003 Sep 1;171(5):2485-95. doi: 10.4049/jimmunol.171.5.2485.
Cell surface receptors belonging to the CD2 subset of the Ig superfamily of molecules include CD2, CD48, CD58, 2B4, signaling lymphocytic activation molecule (SLAM), Ly9, CD84, and the recently identified molecules NTB-A/Ly108/SLAM family (SF) 2000, CD84H-1/SF2001, B lymphocyte activator macrophage expressed (BLAME), and CRACC (CD2-like receptor-activating cytotoxic cells)/CS-1. Some of these receptors, such as CD2, SLAM, 2B4, CRACC, and NTB-A, contribute to the activation and effector function of T cells and NK cells. Signaling pathways elicited via some of these receptors are believed to involve the Src homology 2 (SH2) domain-containing cytoplasmic adaptor protein SLAM-associated protein (SAP), as it is recruited to SLAM, 2B4, CD84, NTB-A, and Ly-9. Importantly, mutations in SAP cause the inherited human immunodeficiency X-linked lymphoproliferative syndrome (XLP), suggesting that XLP may result from perturbed signaling via one or more of these SAP-associating receptors. We have now studied the requirements for SAP recruitment to CD84 and lymphocyte activation elicited following ligation of CD84 on primary and transformed human T cells. CD84 was found to be rapidly tyrosine phosphorylated following receptor ligation on activated T cells, an event that involved the Src kinase Lck. Phosphorylation of CD84 was indispensable for the recruitment of SAP, which was mediated by Y(262) within the cytoplasmic domain of CD84 and by R(32) within the SH2 domain of SAP. Furthermore, ligating CD84 enhanced the proliferation of anti-CD3 mAb-stimulated human T cells. Strikingly, this effect was also apparent in SAP-deficient T cells obtained from patients with XLP. These results reveal a novel function of CD84 on human lymphocytes and suggest that CD84 can activate human T cells via a SAP-independent mechanism.
属于免疫球蛋白超家族分子CD2亚群的细胞表面受体包括CD2、CD48、CD58、2B4、信号淋巴细胞激活分子(SLAM)、Ly9、CD84,以及最近鉴定出的分子NTB-A/Ly108/SLAM家族(SF)2000、CD84H-1/SF2001、巨噬细胞表达的B淋巴细胞激活分子(BLAME)和CRACC(CD2样受体激活细胞毒性细胞)/CS-1。这些受体中的一些,如CD2、SLAM、2B4、CRACC和NTB-A,有助于T细胞和NK细胞的激活及效应功能。据信,通过其中一些受体引发的信号通路涉及含Src同源2(SH2)结构域的细胞质衔接蛋白SLAM相关蛋白(SAP),因为它被招募到SLAM、2B4、CD84、NTB-A和Ly-9。重要的是,SAP中的突变会导致遗传性人类免疫缺陷X连锁淋巴增殖综合征(XLP),这表明XLP可能是由这些与SAP相关的受体中一个或多个的信号传导紊乱所致。我们现在研究了SAP募集到CD84的要求以及在原代和转化的人T细胞上连接CD84后引发的淋巴细胞激活。发现在活化的T细胞上连接受体后,CD84会迅速发生酪氨酸磷酸化,这一事件涉及Src激酶Lck。CD84的磷酸化对于SAP的募集是必不可少的,这是由CD84细胞质结构域内的Y(262)和SAP的SH2结构域内的R(32)介导的。此外,连接CD84可增强抗CD3单克隆抗体刺激的人T细胞的增殖。令人惊讶的是,这种效应在从XLP患者获得的SAP缺陷T细胞中也很明显。这些结果揭示了CD84在人淋巴细胞上的新功能,并表明CD84可以通过一种不依赖SAP的机制激活人T细胞。